Skip to main content

Rosanna Paciucci Barzanti

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Rosanna Paciucci Barzanti

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Caracterització funcional del complex PTOV1-flotilin-1 en la modulació de la proliferació de cèl·lules canceroses: control mitòtic i interacció amb la via Notch

IP: Rosanna Paciucci Barzanti
Collaborators: Joan Morote Robles, Inés de Torres Ramirez, Anna Santamaria Margalef
Funding agency: Fundació La Marató de TV3
Funding: 154973
Reference: TV3/052610
Duration: 01/01/2006 - 31/12/2008

Función del complejo PTOV1/flotilina-1/RACK1 en la proliferación y progresión tumoral. Validación in vivo sobre tissue-arrays de tumores humanos y en el modelo murino TRAMP de cáncer de próstata.

IP: Rosanna Paciucci Barzanti
Collaborators: Anna Santamaria Margalef, Carmela Iglesias i Felip
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 107100
Reference: SAF2005-05848
Duration: 15/10/2005 - 14/10/2008

Ministerio de Ciencia

Participación de laprotína PTOV 1 inductoraa de la proliferación celular en la progresión tumoral en la prótstata en el modelo TRAMP de rfatón transgénico.

IP: Rosanna Paciucci Barzanti
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 10820
Reference: HI2004-0302
Duration: 01/01/2005 - 30/03/2007

Estudi de la funció de la nova proteïna PTOV1 en la proliferació i la invasió del càncer de pròstata

IP: Rosanna Paciucci Barzanti
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 1133
Reference: 2005FI 00579
Duration: 01/01/2005 - 31/12/2008

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model.

Related professionals

Mireia Andres Villarreal

Mireia Andres Villarreal

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Buxo Masip

Xavier Buxo Masip

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Laura Mónica Perez  Bazan

Laura Mónica Perez Bazan

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Estefania De la Torre Villaescusa

Estefania De la Torre Villaescusa

Head of unit
Teaching Promotion
Teaching Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.